Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.

Abstract:

:Enhancement of specific transplantation resistance to a syngeneic tumor (KMT-17) was observed in WKA rats by treatment with the antileukemia drug busulfan (BU) (15 mg/kg) 5 days before and 5 days after immunization with X-irradiated KMT-17 tumor cells. Rats immunized with X-irradiated KMT-17 cells and then treated with BU showed specific transplantation resistance only against KMT-17 tumor. Carrageenan administration after BU treatment had no effect on enhancement by BU, which indicated that macrophages were not playing a major role in the observed enhancement. With the Winn assay, it was found that spleen cells from rats immunized with X-irradiated tumor cells followed by BU inhibited the growth of admixed tumor cells more strongly than did spleen cells from rats only immunized or only BU treated and that the tumor-neutralizing activity of spleen cells from rats treated by immunization followed by BU was abrogated by treatment with anti-T-serum and complement. It was suggested that the enhanced antitumor transplantation resistance caused by BU was due to enhanced T-cell immune responses to tumor cells. Enhancement of anti-tumor transplantation resistance by BU was significantly abrogated by adoptive transfer with thymus cells and was slightly abrogated with spleen cells from rats immunized with X-irradiated KMT-17 cells 1 day before tumor challenge but receiving no other treatment. Transfer of sera from the immunized rats had no effect on enhancement by BU. These results, taken together, suggest that the mechanism of the enhancement by BU involved a selective elimination of the immunosuppressor cells from the immunized hosts.

journal_name

Cancer Res

journal_title

Cancer research

authors

Mizushima Y,Sendo F,Takeichi N,Hosohawa M,Kobayashi H

subject

Has Abstract

pub_date

1981-07-01 00:00:00

pages

2917-21

issue

7

eissn

0008-5472

issn

1538-7445

journal_volume

41

pub_type

杂志文章
  • A morphometrical analysis of lymph node responses to tumors of different immunogenicity.

    abstract::An immunogenic tumor and a nonimmunogenic tumor were used in C57BL/Ka and CBA/Rij mice, respectively, in a study in which lymph node morphology was quantitatively measured. Lymph nodes were cut in semiseries, and a morphometrical analysis was done on the paracortical and cortical areas as major parts of the active lym...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: van de Velde CJ,Meyer CJ,Cornellsse CJ,van der Velde EA,van Putten LM,Swaveling A

    更新日期:1978-03-01 00:00:00

  • Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line).

    abstract::Alkaline phosphatase activity in human endometrial cancer cells of the estrogen-responsive Ishikawa line was markedly stimulated (3-20-fold in 4 days) by estrogens, 5 alpha-dihydrotestosterone, and dehydroepiandrosterone but not by testosterone, medroxyprogesterone acetate, glucocorticoids, several peptide hormones, p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Holinka CF,Hata H,Kuramoto H,Gurpide E

    更新日期:1986-06-01 00:00:00

  • In vivo and in vitro "markers" of human cervical intraepithelial neoplasia.

    abstract::The human uterine cervix offers a unique opportunity to study the early lesions of squamous cell carcinoma, i.e., carcinoma in situ and dysplasia [combined as cervical intraepithelial neoplasia (CIN)]. In vivo, the patients with CIN have the epidemiological common denominators or "markers" of early onset of coitus, mu...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Wilbanks GD

    更新日期:1976-07-01 00:00:00

  • Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.

    abstract::We examined mutations in BRAF exons 11 and 15 and N-RAS exons 2 and 3, in 77 metastatic melanoma cases and 11 melanoma cell lines. Significant differences in the mutation rates observed at different metastatic sites could not be detected. The most frequent mutation, the V599E amino acid substitution in BRAF exon 15, w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gorden A,Osman I,Gai W,He D,Huang W,Davidson A,Houghton AN,Busam K,Polsky D

    更新日期:2003-07-15 00:00:00

  • Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.

    abstract::[SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4- butane-diamine-N,N')platinum (CI-973) is a cisplatin analogue that is currently in clinical trial. Preclinically, CI-973 retained activity against L1210, P388, K562, and human ovarian carcinoma sublines resistant to cisplatin in vitro. CI-973 also retained ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Elliott WL,Roberts BJ,Howard CT,Leopold WR 3rd

    更新日期:1994-08-15 00:00:00

  • Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.

    abstract::Dendritic cells (DCs) are professional antigen-presenting cells, well equipped to initiate an immune response. Currently, tumor antigen-derived peptide loaded DCs are used in clinical vaccination in cancer patients. However, the optimal dose and route of administration of a DC vaccine still remain to be determined. Us...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Eggert AA,Schreurs MW,Boerman OC,Oyen WJ,de Boer AJ,Punt CJ,Figdor CG,Adema GJ

    更新日期:1999-07-15 00:00:00

  • Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model.

    abstract::Although the aromatase inhibitor anastrozole has been shown to be very effective in the treatment of hormone-dependent postmenopausal breast cancer, some patients with advanced disease will develop resistance to treatment. To investigate therapeutic strategies to overcome resistance to anastrozole treatment, we have u...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6807

    authors: Macedo LF,Sabnis GJ,Goloubeva OG,Brodie A

    更新日期:2008-05-01 00:00:00

  • Gaussian Mixture Models for Probabilistic Classification of Breast Cancer.

    abstract::In the era of omics-driven research, it remains a common dilemma to stratify individual patients based on the molecular characteristics of their tumors. To improve molecular stratification of patients with breast cancer, we developed the Gaussian mixture model (GMM)-based classifier. This probabilistic classifier was ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-0573

    authors: Prabakaran I,Wu Z,Lee C,Tong B,Steeman S,Koo G,Zhang PJ,Guvakova MA

    更新日期:2019-07-01 00:00:00

  • Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

    abstract::We previously demonstrated that mutational inactivation of transforming growth factor beta type II receptors (RIIs) is very common among the 13% of human colon cancers with microsatellite instability. These mutations principally cluster in the BAT-RII polyadenine sequence repeat. Among microsatellite stable (MSS) colo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Grady WM,Myeroff LL,Swinler SE,Rajput A,Thiagalingam S,Lutterbaugh JD,Neumann A,Brattain MG,Chang J,Kim SJ,Kinzler KW,Vogelstein B,Willson JK,Markowitz S

    更新日期:1999-01-15 00:00:00

  • Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.

    abstract::FET cells, derived from an early-stage colon carcinoma, are nontumorigenic in athymic mice. Stable transfection of a dominant-negative transforming growth factor beta (TGFbeta) type II receptor (DNRII) into FET cells that express autocrine TGFbeta shows loss of TGFbeta signaling and increased tumorigenicity in vivo in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5348

    authors: Wang J,Yang L,Yang J,Kuropatwinski K,Wang W,Liu XQ,Hauser J,Brattain MG

    更新日期:2008-05-01 00:00:00

  • Effects of nine N-nitroso compounds on the specific radioactivity of liver proteins after injection of [14C]leucine into rats.

    abstract::We compared the effect of nine N-nitroso compounds, given by gavage to adult rats, on specific radioactivity of the trichloroacetic acid-precipitable liver proteins, 1 hr after the injection of [14C]leucine. The specific radioactivity was decreased by dimethylnitrosamine, diethylnitrosamine, methyl-n-butylnitrosamine,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chu C,Mirvish SS

    更新日期:1977-05-01 00:00:00

  • Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors.

    abstract::Colorectal cancers from the mutator phenotype pathway display distinctive pathological features and confer a lesser aggressiveness than colorectal adenocarcinomas originated by the suppressor pathway. The goal of this work was to test whether tumors developed through the mutator pathway could show a decrease in matrix...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Morán A,Iniesta P,de Juan C,González-Quevedo R,Sánchez-Pernaute A,Díaz-Rubio E,Ramón y Cajal S,Torres A,Balibrea JL,Benito M

    更新日期:2002-07-01 00:00:00

  • Human rhabdosarcoma cell-induced aggregation of blood platelets.

    abstract::The ability of tumor cells shed into the circulation to cause adhesion and aggregation of blood platelets may be involved in successful metastasis of primary tumors. Rhabdosarcoma is a rare, early metastasizing tumor previously uncharacterized for ability to alter platelet function. It was found that human rhabdosarco...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Longenecker GL,Beyers BJ,Bowen RJ,King T

    更新日期:1989-01-01 00:00:00

  • IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo.

    abstract::In solid tumors, cancer cells subjected to ischemic conditions trigger distinct signaling pathways contributing to angiogenic stimulation and tumor development. Characteristic features of tumor ischemia include hypoxia and glucose deprivation, leading to the activation of hypoxia-inducible factor-1-dependent signaling...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3235

    authors: Drogat B,Auguste P,Nguyen DT,Bouchecareilh M,Pineau R,Nalbantoglu J,Kaufman RJ,Chevet E,Bikfalvi A,Moenner M

    更新日期:2007-07-15 00:00:00

  • Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth.

    abstract::Cyclooxygenase, involved in tumor growth and angiogenesis, converts arachidonic acid to prostaglandin (PG)H(2), which is immediately converted to bioactive prostanoids including PGE(2), PGD(2), thromboxane (TX)A(2) and PGI(2). To test the hypothesis that changes in the prostanoid profile alter cancer growth, we transd...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pradono P,Tazawa R,Maemondo M,Tanaka M,Usui K,Saijo Y,Hagiwara K,Nukiwa T

    更新日期:2002-01-01 00:00:00

  • Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

    abstract::Genetic abnormalities were assessed in 56 benign, low-, and high-grade ovarian tumors using comparative genomic hybridization (CGH) and analysis of loss of heterozygosity (LOH). In addition, 95 epithelial tumors were analyzed for microsatellite repeat instability. DNA sequence copy number abnormalities (CNAs) were not...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Iwabuchi H,Sakamoto M,Sakunaga H,Ma YY,Carcangiu ML,Pinkel D,Yang-Feng TL,Gray JW

    更新日期:1995-12-15 00:00:00

  • Effects of prostacyclin on tumor cell-induced platelet aggregation.

    abstract::Prostacyclin has been evaluated for its ability to inhibit tumor cell-induced platelet aggregation (TCIPA) induced by several rodent tumor lines: B16a (melanoma); 3LL (carcinoma); 15091A (adenocarcinoma); and W256 (carcinosarcoma). Aggregation of human platelets by all four lines was inhibited by prostaglandin I2 (PGI...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Menter DG,Onoda JM,Taylor JD,Honn KV

    更新日期:1984-02-01 00:00:00

  • Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity.

    abstract::The p53 tumor suppressor gene product is known to be active in mediating radiation-induced G1-S cell cycle arrest and apoptosis in a number of normal cell lines. These functions are compromised by inactivation of p53, which promotes tumor progression. Because the p53 gene appears to play an important role in the cellu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gallardo D,Drazan KE,McBride WH

    更新日期:1996-11-01 00:00:00

  • Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.

    abstract::Epidermal growth factor receptor (EGFR) expression by human breast cancer has been shown to predict poor patient outcome, as has amplification of the c-erbB-2 proto-oncogene. We have developed a quantitative immunohistochemical method for measuring protein levels of both receptors and have applied this to a series of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Robertson KW,Reeves JR,Smith G,Keith WN,Ozanne BW,Cooke TG,Stanton PD

    更新日期:1996-08-15 00:00:00

  • Navitoclax (ABT-263) accelerates apoptosis during drug-induced mitotic arrest by antagonizing Bcl-xL.

    abstract::Combining microtubule-targeting antimitotic drugs with targeted apoptosis potentiators is a promising new chemotherapeutic strategy to treat cancer. In this study, we investigate the cellular mechanism by which navitoclax (previously called ABT-263), a Bcl-2 family inhibitor, potentiates apoptosis triggered by paclita...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-4336

    authors: Shi J,Zhou Y,Huang HC,Mitchison TJ

    更新日期:2011-07-01 00:00:00

  • Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.

    abstract::The growth inhibitory effects of combinations of antifolates on hepatoma cells in culture have been examined. In these studies methotrexate or the lipophilic inhibitors of dihydrofolate reductase were used with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolate (PDDF). Under certain conditions partial ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Galivan J,Nimec Z,Rhee M

    更新日期:1987-10-15 00:00:00

  • High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors.

    abstract::Proteasome inhibitors such as bortezomib exhibit clinical efficacy in multiple myeloma, but studies in acute myeloid leukemia (AML) have been disappointing to date. The apparent failure in AML likely reflects a lack of biological understanding that might clarify applications of proteosome inhibitors in this disease. H...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-3018

    authors: Rushworth SA,Bowles KM,MacEwan DJ

    更新日期:2011-03-01 00:00:00

  • Influences of diet and strain on the proliferative effect on the rat urinary bladder induced by sodium saccharin.

    abstract::Rats were fed sodium saccharin as 5 or 7.5% of the diet by weight, and proliferation of the bladder epithelium was assessed by autoradiography, histology, and scanning electron microscopy. In Experiment 1, male F344 rats, 5 weeks old, were placed on a diet of 0, 5, or 7.5% NaS mixed in Prolab 3200, NIH-07, or AIN-76A ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Garland EM,Sakata T,Fisher MJ,Masui T,Cohen SM

    更新日期:1989-07-15 00:00:00

  • Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death.

    abstract::To define genetic determinants of tumor cell resistance to the cytotoxic action of tumor necrosis factor alpha (TNF), we have applied cDNA microarrays to a human breast carcinoma TNF-sensitive MCF7 cell line and its established TNF-resistant clone. Of a total of 5760 samples of cDNA examined, 3.6% were found to be dif...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-1735

    authors: Diarra-Mehrpour M,Arrabal S,Jalil A,Pinson X,Gaudin C,Piétu G,Pitaval A,Ripoche H,Eloit M,Dormont D,Chouaib S

    更新日期:2004-01-15 00:00:00

  • ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.

    abstract::Chromatin coregulators are important factors in tumorigenesis and cancer progression. ANCCA is an AAA+ ATPase and a bromodomain-containing nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells. In t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1199

    authors: Kalashnikova EV,Revenko AS,Gemo AT,Andrews NP,Tepper CG,Zou JX,Cardiff RD,Borowsky AD,Chen HW

    更新日期:2010-11-15 00:00:00

  • Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

    abstract::The interleukin (IL)-13 receptor alpha2 (IL-13Ralpha2) chain is a primary binding and internalization subunit for a Th2-derived immune regulatory cytokine, IL-13. Although extremely high levels of IL-13Ralpha2 chain are expressed on a variety of human tumor cells and specimens, its precise role in tumor immunology has...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1265

    authors: Kawakami K,Terabe M,Kawakami M,Berzofsky JA,Puri RK

    更新日期:2006-04-15 00:00:00

  • The CpG island methylator phenotype is not associated with a personal or family history of cancer.

    abstract::Colorectal cancers with widespread CpG island methylation display a number of distinct clinicopathological features, and it has been suggested that the condition has an inheritable genetic component. To address this possibility, histories of cancer were obtained from 562 individuals undergoing curative surgery for uns...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3978

    authors: Ward RL,Williams R,Law M,Hawkins NJ

    更新日期:2004-10-15 00:00:00

  • Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.

    abstract::Vaccination with irradiated tumor cells genetically modified to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF tumor vaccine) induces a potent systemic antitumor immunity. To develop a protocol for cancer therapy to further augment the host immune response, we examined the effects of the GM-CSF tumor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wakimoto H,Abe J,Tsunoda R,Aoyagi M,Hirakawa K,Hamada H

    更新日期:1996-04-15 00:00:00

  • Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats.

    abstract::Sodium saccharin and sodium ascorbate are known to promote urinary bladder carcinogenesis in rats following initiation with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) or N-butyl-N-(4-hydroxybutyl) nitrosamine. Sodium salts of other organic acids have also been shown to be bladder tumor promoters. In addition...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cohen SM,Ellwein LB,Okamura T,Masui T,Johansson SL,Smith RA,Wehner JM,Khachab M,Chappel CI,Schoenig GP

    更新日期:1991-04-01 00:00:00

  • Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

    abstract::Immunization to multiple defined tumor antigens for specific immune therapy of human cancer has thus far proven difficult. Eighteen HLA A*0201(+) patients with metastatic melanoma received injections s.c. of CD34(+)progenitor-derived autologous dendritic cells (DCs), which included Langerhans cells. DCs were pulsed wi...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Banchereau J,Palucka AK,Dhodapkar M,Burkeholder S,Taquet N,Rolland A,Taquet S,Coquery S,Wittkowski KM,Bhardwaj N,Pineiro L,Steinman R,Fay J

    更新日期:2001-09-01 00:00:00